DOI: 10.1055/s-00043364

Pharmaceutical Fronts

References

Shi D, Zhan X, Yu X. et al.
Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.

Lipids Health Dis 2014;
13: 173

Download Bibliographical Data

Access:
Access: